Ablexis, LLC
Ablexis, LLC, a pioneering biotechnology company headquartered in the United States, has been at the forefront of antibody discovery since its establishment in 2010. With a strong operational presence across North America and Europe, Ablexis focuses on developing innovative solutions for therapeutic antibody generation, utilising its proprietary AlivaMab® platform. The company’s core offerings include the AlivaMab platform, which enables the rapid and efficient creation of fully human monoclonal antibodies. This unique technology streamlines the drug development process, significantly reducing time and costs for clients in the pharmaceutical and biotechnology sectors. Recognised for its contributions to the industry, Ablexis has established a solid market position, collaborating with leading biopharmaceutical companies to advance therapeutic options for various diseases. With a commitment to innovation and excellence, Ablexis continues to shape the future of antibody therapeutics.
DitchCarbon Score
How does Ablexis, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Ablexis, LLC's score of 18 is higher than 52% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Ablexis, LLC's reported carbon emissions
Ablexis, LLC, headquartered in the US, currently does not have any publicly available carbon emissions data or specific reduction targets. Without concrete figures or commitments, it is challenging to assess their climate impact or initiatives. However, the absence of emissions data suggests that the company may still be in the early stages of developing a comprehensive climate strategy. As the industry increasingly prioritises sustainability, it is essential for organisations like Ablexis to establish clear climate commitments and reduction targets to align with global efforts in mitigating climate change.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Ablexis, LLC is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
